Alnylam Pharmaceuticals Inc

Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT

Alnylam Pharmaceuticals Inc (ALNY) SEC filings

Alnylam Pharmaceuticals Inc (ALNY) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported ALNY revenue for 2025-12-31 was $3.71B. Net income was $313.7M. Revenue was up 65.2% from 2024-12-31 to 2025-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 37.5. The ALNY filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Alnylam Pharmaceuticals Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for ALNY — what management said, what changed, and why it matters.

Recent filings

These filings as JSON? API free 100/day

ALNY SEC filings FAQ

What is the latest ALNY SEC filing?

The latest cached Alnylam Pharmaceuticals Inc (ALNY) filing on this page is 8-K · Jul 30, 2026. Filings: https://lician.com/sec/alny

What is the latest ALNY filing accession number?

The latest cached Alnylam Pharmaceuticals Inc (ALNY) accession number on this page is 0001178670-26-000060. Filing: https://lician.com/sec/alny/0001178670-26-000060

Which item codes are on the latest ALNY filing?

Cached item codes on the latest Alnylam Pharmaceuticals Inc (ALNY) 8-K are 2.02, 9.01.

How many ALNY SEC filings are listed on this page?

This page lists 2 cached Alnylam Pharmaceuticals Inc (ALNY) SEC filings. Filings: https://lician.com/sec/alny

What events are listed on the ALNY SEC page?

Cached event headlines on this Alnylam Pharmaceuticals Inc (ALNY) SEC page: "ALNY earnings". Events: https://lician.com/sec/alny

What is ALNY's P/E ratio?

Alnylam Pharmaceuticals Inc (ALNY) trailing P/E is 37.5 on the latest cached fundamentals snapshot.

What are ALNY's latest revenue and net income?

Latest cached Alnylam Pharmaceuticals Inc (ALNY) revenue for Dec 31, 2025 was $3.71B. Net income was $313.7M. Statements: https://lician.com/financials/alny